Term Sheet VC EU: Venture Capital Agreements Under MiCA 2024

What Is a Term Sheet in European Union Venture Capital Transactions?

A term sheet in EU venture capital context is a non-binding or partially binding document that outlines the principal commercial and legal terms of a proposed investment between a venture capital fund and a startup or scale-up. While the document itself predates regulatory frameworks, the European Union's evolving legal landscape — particularly the Markets in Crypto-Assets Regulation (MiCA), the Alternative Investment Fund Managers Directive (AIFMD II), and the European Venture Capital Regulation (EuVECA) — has fundamentally reshaped what must appear in a term sheet EU context and how VC investment Europe operates at the structural level.

For founders raising capital in the EU — whether for a traditional technology startup, a tokenized asset platform, or a Web3 infrastructure project — understanding what drives term sheet construction under EU law is no longer optional. Investors operating under MiCA-licensed structures, EuVECA passports, or AIFMD-compliant fund vehicles impose specific contractual obligations that trace directly back to the term sheet negotiation stage. This guide breaks down the regulatory framework, mandatory clauses, and practical processes that define a compliant and commercially defensible venture capital agreement EU.

Legal Requirements and Regulatory Framework Governing VC Term Sheets in the EU

Unlike the United States, which relies heavily on Delaware corporate law and NVCA model documents, the EU does not have a single harmonized term sheet standard. Instead, the framework is assembled from several interlocking regulations and directives:

• MiCA (Regulation EU 2023/1114): Fully applicable from December 30, 2024, MiCA governs the issuance and trading of crypto-assets across the EU. For VC deals involving token issuance, SAFT agreements, or equity-token hybrids, MiCA compliance must be reflected in the term sheet from day one. The European Securities and Markets Authority (ESMA) and the European Banking Authority (EBA) are the primary supervisory bodies.
• EuVECA Regulation (EU 648/2013, amended): Allows qualifying VC managers to raise capital across the EU under a single passport. Funds using the EuVECA label must invest at least 70% of their capital in qualifying portfolio companies, defined as unlisted SMEs with fewer than 250 employees. Term sheets must reflect this qualifying investment threshold.
• AIFMD II (Directive 2024/927/EU): Applies to VC managers whose assets under management exceed the €100 million (leveraged) or €500 million (unleveraged) thresholds. AIFMD II imposes enhanced disclosure, remuneration, and liquidity management obligations that filter into term sheet representations and warranties.
• National Corporate Law: Term sheets and subsequent investment documents are governed by the law of the portfolio company's jurisdiction of incorporation. Key jurisdictions include the Netherlands (BV structure under Dutch Civil Code), Luxembourg (SARL under the Law of August 10, 1915), Ireland (Limited Company under Companies Act 2014), and Estonia (OÜ structure, popular for e-Residency-based startups).
• GDPR (Regulation EU 2016/679): Data sharing during due diligence and post-investment reporting must be addressed in term sheet confidentiality and data governance provisions.

Key Clauses in a Term Sheet VC EU — Specific Requirements

A well-structured term sheet EU for venture capital investment should address the following core areas with precision:

1. Valuation and Investment Structure

Pre-money and post-money valuations must be clearly stated. EU investors frequently structure investments through convertible notes, SAFEs adapted for EU jurisdictions (often called CLAs — Convertible Loan Agreements), or direct equity. For MiCA-regulated projects, the term sheet must specify whether the investment is in equity, utility tokens, asset-referenced tokens (ARTs), or e-money tokens (EMTs) — each carrying distinct regulatory consequences under MiCA Articles 16–46.

2. Liquidation Preference

EU term sheets typically use 1x non-participating liquidation preferences as the market standard, particularly for Seed and Series A rounds. Participating preferred structures exist but face pushback in founder-friendly markets like Berlin, Amsterdam, and Stockholm. The liquidation waterfall must account for local corporate law restrictions — for example, Dutch BV law requires that distributions respect the company's balance sheet test under Article 2:216 of the Dutch Civil Code.

3. Anti-Dilution Provisions

Broad-based weighted average anti-dilution is the EU standard. Full ratchet provisions are rare and increasingly viewed as investor-hostile in European VC markets. The calculation base must be defined precisely to avoid disputes during down-round scenarios.

4. Governance and Board Composition

EU investors commonly require one board seat per lead investor. Under AIFMD II, fund managers must document governance oversight in their annual reports. Term sheets should specify board observer rights, veto rights (reserved matters), and information rights including quarterly financials and annual audited accounts.

5. MiCA-Specific Token Provisions

Where the venture capital agreement EU involves a crypto-asset project, the term sheet must address: the type of crypto-asset under MiCA classification (utility token vs. ART vs. EMT), the obligation to publish a MiCA-compliant white paper prior to public offer, ESMA notification timelines, and the liability regime under MiCA Article 19 for inaccurate white paper disclosures. Token lockup periods and vesting schedules for team and investor allocations should also be specified.

6. Conditions Precedent

Standard EU conditions precedent include satisfactory legal and financial due diligence, regulatory approvals (including MiCA authorization from the relevant national competent authority, such as the AFM in the Netherlands, the BaFin in Germany, or the CBI in Ireland), and shareholder approval where required by national corporate law.

7. Exclusivity and No-Shop

Exclusivity periods of 30–60 days are standard in VC investment Europe. The clause must define the scope carefully — blanket no-shop provisions can trigger competition law concerns if the investor is a strategic corporate VC subject to EU merger control thresholds.

Step-by-Step Process for Executing a VC Term Sheet in the EU

• Step 1 — Pre-Term Sheet Preparation: Founders should prepare a capitalization table, a draft corporate structure chart, and — for MiCA-scope projects — a preliminary token classification analysis. Engage EU-qualified legal counsel before term sheet negotiation begins.
• Step 2 — Term Sheet Negotiation: Use market-standard frameworks such as the Invest Europe model term sheet or jurisdiction-specific templates from the British Private Equity and Venture Capital Association (BVCA) adapted for EU law. Negotiate valuation, governance, and protective provisions simultaneously rather than sequentially.
• Step 3 — Regulatory Pre-Clearance: For MiCA-regulated projects, file for authorization or notification with the national competent authority before closing. MiCA Article 15 requires that issuers of asset-referenced tokens obtain prior authorization from ESMA-supervised national authorities. Processing timelines range from 25 business days (utility tokens, notification only) to 3 months (ARTs, full authorization).
• Step 4 — Due Diligence: EU investors conduct legal, financial, and technical due diligence. For crypto projects, smart contract audits and MiCA white paper review are standard. GDPR-compliant data room protocols must be in place.
• Step 5 — Definitive Documentation: The term sheet feeds into a Shareholders Agreement (SHA), Subscription Agreement, and Articles of Association amendment. In Luxembourg and the Netherlands, notarial deeds are required for share issuance.
• Step 6 — Closing and Post-Closing Obligations: Funds are transferred upon satisfaction of conditions precedent. Post-closing, investors may require MiCA white paper publication, ESMA notification filing, and delivery of audited financials within agreed timelines.

Common Mistakes to Avoid in EU VC Term Sheets

• Ignoring MiCA classification early: Treating all token instruments as utility tokens without formal MiCA classification analysis exposes both founders and investors to regulatory enforcement risk post-closing.
• Using US-style SAFE agreements without adaptation: Standard Y Combinator SAFEs are not directly enforceable in many EU jurisdictions. Dutch, German, and French courts have treated unadapted SAFEs inconsistently. Use jurisdiction-specific CLAs instead.
• Omitting national corporate law constraints: Liquidation preferences and anti-dilution mechanisms that work under Delaware law may be void or unenforceable under Dutch, German, or French corporate law if they conflict with statutory shareholder protections.
• Underspecifying information rights: AIFMD II-regulated investors have mandatory reporting obligations to their own LPs. Term sheets that provide inadequate information rights create downstream compliance failures for fund managers.
• Neglecting GDPR in confidentiality clauses: Data shared during due diligence constitutes personal data processing under GDPR. Term sheets should include a data processing annex or GDPR-compliant confidentiality framework.

Frequently Asked Questions

Is a term sheet legally binding in EU venture capital transactions?

In most EU jurisdictions, term sheets are predominantly non-binding with specific carve-outs for exclusivity, confidentiality, and governing law clauses, which are binding. However, under Dutch and German law, prolonged negotiation on the basis of a term sheet can create pre-contractual liability (culpa in contrahendo) if one party withdraws without justification after the counterparty has incurred substantial reliance costs. Founders and investors should expressly state which provisions are binding and which are not.

How does MiCA affect term sheet drafting for crypto startups raising VC in the EU?

MiCA directly impacts term sheets for crypto projects by requiring that the investment structure account for the regulatory classification of the crypto-asset, mandatory white paper publication obligations, ongoing issuer liability under MiCA Articles 19 and 82, and the requirement to obtain authorization from a national competent authority before certain token offers. Term sheets should include representations that the company is MiCA-compliant or on a defined path to compliance, with closing conditions tied to regulatory milestones.

What is the difference between EuVECA and AIFMD fund structures for VC term sheet purposes?

EuVECA funds operate under a lighter regulatory regime and are capped in terms of AUM. They must invest in qualifying SMEs and are restricted from using leverage beyond limited operational borrowing. AIFMD-regulated funds have broader investment mandates but face heavier compliance obligations. For founders, the practical difference lies in the information rights and reporting requirements that the investor will demand in the term sheet and SHA — AIFMD funds require more granular portfolio company data to satisfy their own regulatory reporting obligations to national competent authorities.

Which EU jurisdiction is most favorable for VC investment structures?

Luxembourg remains the dominant jurisdiction for EU VC fund domiciliation due to its SOPARFI holding company regime, SCSp limited partnership structure, and proximity to ESMA. For portfolio company incorporation, the Netherlands (BV), Ireland (Limited Company), and Estonia (OÜ) are preferred by international VC investors for their flexible corporate law, English-language legal systems, and EU regulatory recognition. The choice of jurisdiction should be reflected in the governing law and dispute resolution clause of the term sheet.

Can a term sheet EU include token warrants or SAFTs under MiCA?

Yes, but with significant structuring care. Simple Agreements for Future Tokens (SAFTs) must be analyzed under MiCA to determine whether the future tokens constitute financial instruments under MiFID II, in which case the SAFT itself may constitute a transferable security requiring a prospectus. Token warrants attached to equity investments may be structured as ancillary rights if the primary instrument is equity, but the token component must still satisfy MiCA's white paper and issuer liability requirements upon token generation. Legal counsel with dual expertise in EU securities law and MiCA is essential.